Persistent clinical efficacy and excellent safety over 5 years of treatment with the anti-TNFA agent infliximab in patients with ankylosing spondylitis
ANNALS OF THE RHEUMATIC DISEASES(2006)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
ANNALS OF THE RHEUMATIC DISEASES(2006)